Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2006-05-03

Clinical Trial Update: Zinc Supplementation in Shigella Patients [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating zinc supplementation in patients with Shigella infection has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zinc sulfate (Zinc sulfate)

Snippet

Sponsor: International Centre for Diarrhoeal Disease Research, Bangladesh | Conditions: Testing Effect of Intervention | Phase 3 | Status: COMPLETED